http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-0203551-D0
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_379a600b6d7f336a460fafea157cec22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 |
| filingDate | 2002-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc1a4ec1c297fad7098afede922ba44f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a2748c8ce74e9679aec630880f35876 |
| publicationDate | 2002-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SE-0203551-D0 |
| titleOfInvention | Prothrombin purification |
| abstract | One aspect of the invention relates to a process for the preparation of a purified solution of prothrombin and factor X from a fraction of blood plasma obtainable by cryoprecipitation, which process comprises subjecting such a fraction to prepurification steps and to the following steps: (a) metal chelate gel chromatography and (b) affinity gel chromatography. Another aspect of the invention relates to a solution of prothrombin and factor X, wherein the prothrombin has the ability of being activated to thrombin in the substantial absence of other enzymes or cofactors. A further aspect of the invention relates to the use of a solution of prothrombin and factor X for the preparation of a thrombin solution. |
| priorityDate | 2002-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.